nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—Masoprocol—IGF1R—bone cancer	0.0155	0.833	CrCbGaD
Isoprenaline—Salbutamol—CYP3A4—bone cancer	0.00214	0.115	CrCbGaD
Isoprenaline—Epinephrine—CYP3A4—bone cancer	0.000967	0.052	CrCbGaD
Isoprenaline—PIK3R1—Signaling by NGF—EGFR—bone cancer	0.000192	0.000196	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—EGFR—bone cancer	0.000192	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000192	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—EGFR—bone cancer	0.000192	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—MDM2—bone cancer	0.000191	0.000195	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—MDM2—bone cancer	0.00019	0.000194	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—EGFR—bone cancer	0.00019	0.000193	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000188	0.000192	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—EGFR—bone cancer	0.000187	0.000191	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—DHFR—bone cancer	0.000185	0.000189	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—KIT—bone cancer	0.000183	0.000187	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000183	0.000186	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—SMO—bone cancer	0.000182	0.000186	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—EGFR—bone cancer	0.000181	0.000184	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.00018	0.000184	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—GNA11—bone cancer	0.000179	0.000182	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—JUN—bone cancer	0.000177	0.00018	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RGS1—bone cancer	0.000176	0.00018	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GRM4—bone cancer	0.000176	0.00018	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—GNA11—bone cancer	0.000176	0.000179	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFBR2—bone cancer	0.000174	0.000177	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—GNA11—bone cancer	0.000173	0.000176	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—PLAU—bone cancer	0.000173	0.000176	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—CDK4—bone cancer	0.000172	0.000176	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NT5C3A—bone cancer	0.000172	0.000175	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—JUN—bone cancer	0.000172	0.000175	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.00017	0.000173	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—EGFR—bone cancer	0.00017	0.000173	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—KIT—bone cancer	0.000169	0.000173	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—JUN—bone cancer	0.000169	0.000173	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TP53—bone cancer	0.000168	0.000171	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—GNA11—bone cancer	0.000167	0.00017	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—CDK4—bone cancer	0.000166	0.00017	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MET—bone cancer	0.000166	0.00017	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ATF1—bone cancer	0.000166	0.000169	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—GSTP1—bone cancer	0.000166	0.000169	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000164	0.000167	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ATF1—bone cancer	0.000164	0.000167	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IGF1R—bone cancer	0.000164	0.000167	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—EGFR—bone cancer	0.000163	0.000166	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ENO2—bone cancer	0.000162	0.000165	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL3—bone cancer	0.000162	0.000165	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFBR2—bone cancer	0.00016	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—MDM2—bone cancer	0.00016	0.000163	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL3—bone cancer	0.00016	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—BRAF—bone cancer	0.000159	0.000162	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SMO—bone cancer	0.000158	0.000161	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TP53—bone cancer	0.000158	0.000161	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CYP3A4—bone cancer	0.000157	0.00016	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—GNA11—bone cancer	0.000156	0.000159	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000156	0.000159	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—SMO—bone cancer	0.000155	0.000158	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—bone cancer	0.000155	0.000158	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SMO—bone cancer	0.000155	0.000157	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—CDK4—bone cancer	0.000154	0.000157	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—MDM2—bone cancer	0.000154	0.000157	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—GNA11—bone cancer	0.000153	0.000156	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GRM1—bone cancer	0.000153	0.000156	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—SMO—bone cancer	0.000152	0.000155	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000151	0.000154	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL3—bone cancer	0.000151	0.000154	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—DHFR—bone cancer	0.00015	0.000153	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GRM4—bone cancer	0.00015	0.000153	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RGS1—bone cancer	0.00015	0.000153	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—RB1—bone cancer	0.00015	0.000153	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RGS1—bone cancer	0.000147	0.00015	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GRM4—bone cancer	0.000147	0.00015	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—KIT—bone cancer	0.000146	0.000149	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MMP9—bone cancer	0.000146	0.000149	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GNA11—bone cancer	0.000145	0.000148	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—MDM2—bone cancer	0.000145	0.000147	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—KIT—bone cancer	0.000144	0.000147	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—GNA11—bone cancer	0.000142	0.000145	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL3—bone cancer	0.000142	0.000144	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ATF1—bone cancer	0.000142	0.000144	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GNA11—bone cancer	0.000141	0.000144	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—JUN—bone cancer	0.000139	0.000142	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—GNA11—bone cancer	0.000139	0.000142	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP2—bone cancer	0.000139	0.000141	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL3—bone cancer	0.000139	0.000141	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFBR2—bone cancer	0.000139	0.000141	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—KIT—bone cancer	0.000138	0.000141	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL3—bone cancer	0.000138	0.000141	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFBR2—bone cancer	0.000137	0.000139	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—EGFR—bone cancer	0.000135	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—KIT—bone cancer	0.000135	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ATF1—bone cancer	0.000135	0.000137	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—GSTP1—bone cancer	0.000134	0.000137	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—RB1—bone cancer	0.000134	0.000136	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—MDM2—bone cancer	0.000133	0.000136	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—EGFR—bone cancer	0.000133	0.000136	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—KIT—bone cancer	0.000133	0.000136	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ATF1—bone cancer	0.000131	0.000134	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL3—bone cancer	0.000131	0.000134	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—EGFR—bone cancer	0.000131	0.000133	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IGF1R—bone cancer	0.00013	0.000133	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GRM1—bone cancer	0.00013	0.000133	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—EGFR—bone cancer	0.00013	0.000132	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL3—bone cancer	0.000129	0.000131	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—PTGS2—bone cancer	0.000129	0.000131	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IGF1R—bone cancer	0.000128	0.000131	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL3—bone cancer	0.000128	0.000131	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GRM1—bone cancer	0.000127	0.00013	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—BRAF—bone cancer	0.000127	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—bone cancer	0.000126	0.000128	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL3—bone cancer	0.000126	0.000128	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—JUN—bone cancer	0.000126	0.000128	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—BRAF—bone cancer	0.000125	0.000127	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—KIT—bone cancer	0.000119	0.000121	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—KIT—bone cancer	0.000119	0.000121	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—EGFR—bone cancer	0.000118	0.00012	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—bone cancer	0.000117	0.000119	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—MDM2—bone cancer	0.000115	0.000117	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—MDM2—bone cancer	0.000114	0.000116	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—MDM2—bone cancer	0.000113	0.000116	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFBR2—bone cancer	0.000112	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—BRAF—bone cancer	0.000112	0.000114	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFBR2—bone cancer	0.00011	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—EGFR—bone cancer	0.00011	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—KIT—bone cancer	0.000109	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFBR2—bone cancer	0.000109	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—MDM2—bone cancer	0.000109	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—EGFR—bone cancer	0.000108	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PTGS2—bone cancer	0.000108	0.00011	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SMO—bone cancer	0.000108	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MDM2—bone cancer	0.000106	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IGF1R—bone cancer	0.000106	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—EGFR—bone cancer	0.000105	0.000107	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MDM2—bone cancer	0.000105	0.000107	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP9—bone cancer	0.000104	0.000106	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IGF1R—bone cancer	0.000103	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—BRAF—bone cancer	0.000103	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PTGS2—bone cancer	0.000103	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—bone cancer	0.000102	0.000104	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PTGS2—bone cancer	0.000101	0.000103	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—JUN—bone cancer	0.0001	0.000102	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—EGFR—bone cancer	9.88e-05	0.000101	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—JUN—bone cancer	9.86e-05	0.0001	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GNA11—bone cancer	9.84e-05	0.0001	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—JUN—bone cancer	9.47e-05	9.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KIT—bone cancer	9.46e-05	9.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MDM2—bone cancer	9.34e-05	9.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MDM2—bone cancer	9.33e-05	9.51e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KIT—bone cancer	9.32e-05	9.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SMO—bone cancer	9.17e-05	9.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ATF1—bone cancer	9.15e-05	9.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—EGFR—bone cancer	9.12e-05	9.29e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SMO—bone cancer	8.97e-05	9.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL3—bone cancer	8.92e-05	9.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—BRAF—bone cancer	8.89e-05	9.06e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—BRAF—bone cancer	8.76e-05	8.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MDM2—bone cancer	8.62e-05	8.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—EGFR—bone cancer	8.62e-05	8.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PTGS2—bone cancer	8.59e-05	8.75e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—EGFR—bone cancer	8.49e-05	8.65e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—EGFR—bone cancer	8.43e-05	8.59e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GNA11—bone cancer	8.39e-05	8.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTGS2—bone cancer	8.31e-05	8.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GNA11—bone cancer	8.21e-05	8.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—JUN—bone cancer	8.12e-05	8.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—JUN—bone cancer	8.11e-05	8.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KIT—bone cancer	8.06e-05	8.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—bone cancer	7.9e-05	8.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EGFR—bone cancer	7.87e-05	8.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ATF1—bone cancer	7.8e-05	7.95e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EGFR—bone cancer	7.75e-05	7.9e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KIT—bone cancer	7.66e-05	7.81e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFBR2—bone cancer	7.63e-05	7.78e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ATF1—bone cancer	7.63e-05	7.77e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL3—bone cancer	7.61e-05	7.75e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ENO2—bone cancer	7.53e-05	7.67e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KIT—bone cancer	7.48e-05	7.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MDM2—bone cancer	7.45e-05	7.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EGFR—bone cancer	7.44e-05	7.58e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL3—bone cancer	7.44e-05	7.58e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KIT—bone cancer	7.44e-05	7.58e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MDM2—bone cancer	7.34e-05	7.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EGFR—bone cancer	7.27e-05	7.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—BRAF—bone cancer	7.2e-05	7.34e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1R—bone cancer	7.18e-05	7.32e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EGFR—bone cancer	7.16e-05	7.29e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—BRAF—bone cancer	7.03e-05	7.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—BRAF—bone cancer	6.99e-05	7.12e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—DHFR—bone cancer	6.99e-05	7.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—EGFR—bone cancer	6.98e-05	7.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—bone cancer	6.96e-05	7.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—bone cancer	6.94e-05	7.07e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—EGFR—bone cancer	6.81e-05	6.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—bone cancer	6.55e-05	6.68e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GNA11—bone cancer	6.53e-05	6.65e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFBR2—bone cancer	6.51e-05	6.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—JUN—bone cancer	6.47e-05	6.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EGFR—bone cancer	6.39e-05	6.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EGFR—bone cancer	6.38e-05	6.5e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—JUN—bone cancer	6.38e-05	6.5e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFBR2—bone cancer	6.36e-05	6.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MDM2—bone cancer	6.34e-05	6.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—bone cancer	6.3e-05	6.42e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—bone cancer	6.2e-05	6.32e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1R—bone cancer	6.12e-05	6.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MDM2—bone cancer	6.03e-05	6.15e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1R—bone cancer	5.99e-05	6.1e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP3A4—bone cancer	5.92e-05	6.03e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.89e-05	6e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MDM2—bone cancer	5.89e-05	6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EGFR—bone cancer	5.89e-05	6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MDM2—bone cancer	5.86e-05	5.97e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—bone cancer	5.65e-05	5.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—JUN—bone cancer	5.51e-05	5.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—bone cancer	5.36e-05	5.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—JUN—bone cancer	5.25e-05	5.34e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KIT—bone cancer	5.21e-05	5.31e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—JUN—bone cancer	5.12e-05	5.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—bone cancer	5.1e-05	5.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EGFR—bone cancer	5.09e-05	5.19e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTP1—bone cancer	5.06e-05	5.16e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EGFR—bone cancer	5.01e-05	5.11e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—bone cancer	4.98e-05	5.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—BRAF—bone cancer	4.9e-05	4.99e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EGFR—bone cancer	4.75e-05	4.84e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIT—bone cancer	4.44e-05	4.52e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIT—bone cancer	4.34e-05	4.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EGFR—bone cancer	4.34e-05	4.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—bone cancer	4.27e-05	4.35e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—bone cancer	4.21e-05	4.29e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BRAF—bone cancer	4.17e-05	4.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EGFR—bone cancer	4.12e-05	4.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MDM2—bone cancer	4.1e-05	4.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BRAF—bone cancer	4.08e-05	4.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EGFR—bone cancer	4.04e-05	4.12e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EGFR—bone cancer	4.03e-05	4.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EGFR—bone cancer	4e-05	4.08e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EGFR—bone cancer	3.96e-05	4.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JUN—bone cancer	3.57e-05	3.63e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MDM2—bone cancer	3.5e-05	3.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—bone cancer	3.47e-05	3.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—bone cancer	3.46e-05	3.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MDM2—bone cancer	3.42e-05	3.48e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—bone cancer	3.38e-05	3.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUN—bone cancer	3.04e-05	3.1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUN—bone cancer	2.97e-05	3.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—bone cancer	2.96e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—bone cancer	2.89e-05	2.95e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EGFR—bone cancer	2.8e-05	2.86e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—bone cancer	2.62e-05	2.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGFR—bone cancer	2.39e-05	2.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—bone cancer	2.35e-05	2.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGFR—bone cancer	2.34e-05	2.38e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—bone cancer	2.01e-05	2.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—bone cancer	1.96e-05	2e-05	CbGpPWpGaD
